BioMarin Pharmaceutical Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $1.89B | $6.84B | $755.1M |
| FY2024 | $1.33B | $6.99B | $942.8M |
| FY2025 | $1.51B | $7.59B | $1.31B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $1.89B | $6.84B | $755.1M |
| FY2024 | $1.33B | $6.99B | $942.8M |
| FY2025 | $1.51B | $7.59B | $1.31B |